Parexel FSP is hiring Senior Clinical Research Associates & CRA II.
This role is open to current Clinical Research Associates with experience of 2 + years of independent onsite monitoring, all types of visits. Oncology and
audit experience is essential.
Single sponsor dedicated to a worldwide biopharmaceutical company that relentlessly seeks breakthroughs to improve patients’ lives. Their daily innovation contributes to a healthier global community. This is the space where today’s visionaries, solution-seekers, and trailblazers converge to shape tomorrow’s groundbreaking solutions. Together, we have the power to revolutionize patients’ well-being. Every choice and step we make is guided by our unwavering focus on patients, fostering an environment where innovation thrives.
The CRA will be responsible for data integrity, and data quality and ensuring compliance with ICH GCP and local requirements at the site level. Monitoring will be conducted in line with the Study Monitoring Plan (SMP) and will be performed virtually for most activities to supplement on-site visit requirements. The Site Monitor will collaborate with the Site Manager to ensure that the site follows the protocol and is inspection ready and will coordinate with institutions and investigators at the local level.
Experience required:
• A minimum of 2 years experience as a clinical monitor (CRA) with demonstrated experience of monitoring onsite in Turkey.
• Extensive experience in managing complex protocols in Oncology
• Bachelor’s degree or Registered Nurse (RN) in a related field or equivalent combination of education, training, and experience
• Experience in utilizing systems like Siebel Clinical Trial Management System (CTMS), electronic Trial Master File (eTMF), electronic Investigator Site File (eISF) (Florence)
We offer exceptional financial rewards, training, and development. Expect exciting professional challenges but with a healthy work/life balance. We value your welfare just as highly as that of our patients.
Apply today!
#LI-TA1
#LI-REMOTE
